<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Pregnancy &amp; Gestational Diabetes — SugarWise</title><link rel="stylesheet" href="styles.css">
    <link rel="icon" type="image/svg+xml" href="favicon.svg"><link rel="manifest" href="manifest.json"><meta name="theme-color" content="#1a7a5a"><meta property="og:type" content="website"><meta property="og:site_name" content="SugarWise"><meta property="og:url" content="https://aravindcleaerr.github.io/diabetes-guide/pregnancy-gestational.html"><meta property="og:description" content="Free educational diabetes management guide. Not medical advice."><meta property="og:image" content="https://aravindcleaerr.github.io/diabetes-guide/og-image.svg"></head><body>
<a href="#main" class="skip-link">Skip to content</a>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="lang-switch" href="pregnancy-gestational-kn.html">ಕನ್ನಡ</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container" id="main" role="main">
<div class="page-header"><h1>Pregnancy &amp; Gestational Diabetes</h1><p>Managing diabetes before, during, and after pregnancy</p></div>
<div class="last-reviewed">Content last reviewed: January 2026 | AI-assisted content</div>

<div class="illus">
<svg width="120" height="150" viewBox="0 0 120 150" xmlns="http://www.w3.org/2000/svg">
<style>.heartbeat{animation:heartbeat 2s ease-in-out infinite}</style>
<circle cx="60" cy="30" r="18" fill="#fbbf24"/>
<path d="M60 48 Q40 55 35 80 Q32 100 45 120 L55 120 L55 145 L65 145 L65 120 L75 120 Q88 100 85 80 Q80 55 60 48Z" fill="#f97316"/>
<ellipse cx="57" cy="90" rx="12" ry="14" fill="#fbbf24" opacity="0.5"/>
<circle class="heartbeat" cx="57" cy="88" r="5" fill="#e53e3e" opacity="0.7"/>
<circle cx="54" cy="26" r="2" fill="#2d3748"/>
<circle cx="66" cy="26" r="2" fill="#2d3748"/>
<path d="M56 33 Q60 36 64 33" stroke="#2d3748" stroke-width="1.5" fill="none"/>
</svg>
</div>

<div class="timeline">
<div class="timeline-item"><div class="timeline-title">Pre-conception (3+ months before)</div><div class="timeline-text">HbA1c &lt; 6.5%, folic acid 5 mg/day, medication review, complication screening</div></div>
<div class="timeline-item"><div class="timeline-title">First Trimester (weeks 1-12)</div><div class="timeline-text">Screen high-risk individuals for GDM early; switch unsafe medications to insulin</div></div>
<div class="timeline-item"><div class="timeline-title">Second Trimester (weeks 13-28)</div><div class="timeline-text">Universal GDM screening at 24-28 weeks; anatomy scan at 18-20 weeks</div></div>
<div class="timeline-item"><div class="timeline-title">Third Trimester (weeks 29-40)</div><div class="timeline-text">Growth scans, increased monitoring, delivery planning at 37-40 weeks</div></div>
<div class="timeline-item"><div class="timeline-title">Postpartum (6-12 weeks after)</div><div class="timeline-text">75g OGTT to check if glucose normalised; lifelong screening every 1-3 years</div></div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F930;</span> Gestational Diabetes (GDM)</h2>
<p>Gestational diabetes is glucose intolerance first recognized during pregnancy. It affects <strong>5–15% of pregnancies</strong> and is becoming more common due to rising obesity rates and older maternal age.</p>

<h3>Screening and Diagnosis</h3>
<p>All pregnant individuals should be screened between <strong>24–28 weeks of gestation</strong>. Those at high risk should be screened earlier (first trimester).</p>
<table>
<tr><th>Test</th><th>Method</th><th>Diagnostic Thresholds</th></tr>
<tr><td>75 g OGTT (WHO / IADPSG criteria)</td><td>Fasting, 1-hour, and 2-hour glucose after 75 g glucose load</td><td>Fasting ≥ 92 mg/dL, 1-hr ≥ 180 mg/dL, 2-hr ≥ 153 mg/dL (any one value meets criteria)</td></tr>
<tr><td>Two-step approach (ACOG)</td><td>50 g glucose challenge test (GCT), followed by 100 g OGTT if GCT is abnormal</td><td>GCT ≥ 130–140 mg/dL triggers OGTT; OGTT: two or more abnormal values (Carpenter-Coustan criteria)</td></tr>
</table>

<h3>Risk Factors</h3>
<ul>
<li>BMI &gt; 25 (or &gt; 23 in Asian populations)</li>
<li>Age &gt; 25 years</li>
<li>Family history of type 2 diabetes (first-degree relative)</li>
<li>Previous GDM or macrosomic baby (&gt;4 kg)</li>
<li>Polycystic ovary syndrome (PCOS)</li>
<li>South Asian, Hispanic, African, or Indigenous ethnicity</li>
<li>History of unexplained stillbirth</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4CB;</span> Management of GDM</h2>
<h3>Step 1: Medical Nutrition Therapy (MNT)</h3>
<ul>
<li>First-line treatment for all individuals with GDM</li>
<li>Calorie distribution: 33–40% carbohydrates, 20–25% protein, 35–40% healthy fats</li>
<li>Three small meals + 2–3 snacks distributed throughout the day</li>
<li>Emphasize low-glycemic-index carbohydrates (whole grains, legumes, vegetables)</li>
<li>Avoid refined sugars, fruit juices, and white bread/rice</li>
<li>Bedtime snack with protein and complex carbs to prevent overnight fasting ketosis</li>
</ul>

<h3>Step 2: Physical Activity</h3>
<ul>
<li>30 minutes of moderate activity (brisk walking) most days, unless contraindicated</li>
<li>Post-meal walks (10–15 minutes) are particularly effective at reducing post-prandial spikes</li>
</ul>

<h3>Step 3: Insulin (if targets not met after 1–2 weeks of MNT)</h3>
<ul>
<li>Insulin is the preferred pharmacotherapy — it does not cross the placenta</li>
<li>Basal-bolus regimen or premixed insulin depending on the glucose pattern</li>
<li>Metformin may be used as an alternative (does cross the placenta; long-term offspring data still emerging)</li>
<li>Glyburide (glibenclamide) is falling out of favor due to higher neonatal hypoglycemia rates</li>
</ul>

<h3>Blood Sugar Targets During Pregnancy</h3>
<table>
<tr><th>Timing</th><th>Target (mg/dL)</th><th>Target (mmol/L)</th></tr>
<tr><td>Fasting</td><td>&lt; 95</td><td>&lt; 5.3</td></tr>
<tr><td>1-hour post-meal</td><td>&lt; 140</td><td>&lt; 7.8</td></tr>
<tr><td>2-hour post-meal</td><td>&lt; 120</td><td>&lt; 6.7</td></tr>
</table>
<div class="note">These targets are tighter than in non-pregnant adults because even mild hyperglycemia in pregnancy affects fetal development.</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4C5;</span> Preexisting Diabetes and Pregnancy Planning</h2>
<p>If you have type 1 or type 2 diabetes and plan to become pregnant, prepare well in advance:</p>

<h3>Pre-conception Goals</h3>
<ul>
<li><strong>HbA1c &lt; 6.5%</strong> (ideally &lt; 6.0%) for at least 3 months before conception</li>
<li>Stable blood sugars with minimal hypoglycemia</li>
<li>Folic acid supplementation: <strong>5 mg/day</strong> (higher dose than standard 0.4 mg) starting 3 months before conception</li>
<li>Comprehensive complication screening: eyes (retinopathy can worsen during pregnancy), kidneys, thyroid, blood pressure</li>
</ul>
<div class="warning">Poorly controlled diabetes at conception increases the risk of major congenital malformations (heart defects, neural tube defects, skeletal abnormalities) by 3–5 fold. Optimization before conception is critical.</div>

<h3>Medication Changes Required</h3>
<table>
<tr><th>Medication</th><th>Action</th><th>Reason</th></tr>
<tr><td>Metformin</td><td>Switch to insulin (or continue if specialist agrees)</td><td>Crosses placenta; some guidelines allow continuation</td></tr>
<tr><td>Sulfonylureas</td><td>Stop; switch to insulin</td><td>Cross placenta; cause neonatal hypoglycemia</td></tr>
<tr><td>SGLT2 inhibitors</td><td>Stop before conception</td><td>No safety data in pregnancy</td></tr>
<tr><td>GLP-1 agonists</td><td>Stop at least 2 months before conception</td><td>No safety data; long half-life of some agents</td></tr>
<tr><td>DPP-4 inhibitors</td><td>Stop; switch to insulin</td><td>Insufficient safety data</td></tr>
<tr><td>ACE inhibitors / ARBs</td><td>Stop before conception</td><td>Teratogenic — cause renal and cardiac defects</td></tr>
<tr><td>Statins</td><td>Stop before conception</td><td>Contraindicated in pregnancy</td></tr>
<tr><td>Insulin</td><td>Continue and intensify</td><td>Safe; does not cross the placenta</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4C8;</span> Monitoring Schedule During Pregnancy</h2>
<ul>
<li><strong>Blood sugar</strong>: self-monitor 4–7 times daily (fasting, pre-meal, 1-hour post-meal, bedtime). CGM is increasingly recommended.</li>
<li><strong>HbA1c</strong>: check monthly during pregnancy (target &lt; 6.0% if achievable without significant hypoglycemia)</li>
<li><strong>Eye examination</strong>: each trimester if preexisting diabetes (retinopathy can progress rapidly)</li>
<li><strong>Kidney function</strong>: each trimester</li>
<li><strong>Blood pressure</strong>: every visit (pre-eclampsia risk is higher)</li>
<li><strong>Fetal monitoring</strong>: regular ultrasounds for growth, anatomy scan at 18–20 weeks, growth scans in third trimester</li>
<li><strong>Thyroid function</strong>: especially in type 1 diabetes (autoimmune thyroid disease is common)</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F3E5;</span> Delivery Planning</h2>
<ul>
<li>Well-controlled GDM with no complications: delivery can be planned at <strong>39–40 weeks</strong></li>
<li>Insulin-requiring GDM or preexisting diabetes: delivery often planned at <strong>37–39 weeks</strong> depending on control and complications</li>
<li>Macrosomia (estimated fetal weight &gt; 4.5 kg): discuss elective cesarean to reduce birth injury risk</li>
<li>During labor: intravenous insulin and glucose infusion to maintain blood sugar 70–120 mg/dL</li>
<li>Insulin requirements drop dramatically immediately after delivery (placental hormones are gone) — doses are typically halved or returned to pre-pregnancy levels</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F50D;</span> Postpartum Screening for Type 2 Diabetes</h2>
<p>Those who had GDM have a <strong>50% lifetime risk</strong> of developing type 2 diabetes:</p>
<ul>
<li><strong>75 g OGTT at 6–12 weeks postpartum</strong> — to check if glucose has normalized</li>
<li>If normal: repeat screening every <strong>1–3 years</strong> for life</li>
<li>Lifestyle measures (healthy weight, regular exercise, balanced diet) reduce progression by up to 58%</li>
<li>Metformin can be considered for prevention in high-risk individuals</li>
</ul>
<div class="warning">Do not assume that normal blood sugar after delivery means GDM is gone permanently. Lifelong surveillance is essential.</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F476;</span> Breastfeeding Benefits</h2>
<ul>
<li>Breastfeeding is <strong>strongly encouraged</strong> for those with diabetes (all types) who are nursing</li>
<li>Improves insulin sensitivity in the nursing parent</li>
<li>Helps with postpartum weight loss</li>
<li>Reduces the nursing parent's long-term risk of type 2 diabetes by up to 50%</li>
<li>Reduces the baby's future risk of obesity and type 2 diabetes</li>
<li>Insulin is safe during breastfeeding (it is not absorbed orally by the infant)</li>
<li>Metformin is considered safe during breastfeeding (minimal transfer to breast milk)</li>
<li>Monitor for hypoglycemia during and after breastfeeding (calorie expenditure can lower blood sugar)</li>
</ul>
<div class="tip">Keep a snack and glass of water nearby during breastfeeding sessions. The caloric demand of lactation (~500 kcal/day) can cause unexpected blood sugar drops.</div>
</div>

<div class="section see-also"><h3>Related Topics</h3><ul>
<li><a href="diet-nutrition.html">Diet &amp; Nutrition</a></li>
<li><a href="blood-sugar-monitoring.html">Blood Sugar Monitoring</a></li>
<li><a href="insulin-guide.html">Insulin Guide</a></li>
</ul></div>
<div class="page-nav">
<a class="prev" href="workplace-management.html">Workplace Management</a>
<a class="next" href="diabetes-in-elderly.html">Diabetes in the Elderly</a>
</div>
</div>
<div class="disclaimer">This content is for educational purposes only and does not replace professional medical advice. The creators of SugarWise are not medical professionals. Do not start, stop, or change any medication without consulting your doctor. In case of emergency, call 112 (India) or your local emergency number. <a href="terms-of-use.html">Read full Terms of Use &amp; Medical Disclaimer</a></div>
<div class="privacy-notice">SugarWise does not use cookies, collect personal data, or track users.</div>
<div class="footer"><span class="ai-badge">AI-Assisted Content</span><br>SugarWise &bull; Comprehensive Diabetes Management Companion &bull; <a href="terms-of-use.html">Terms of Use</a> &bull; Last updated: January 2026</div>
<button class="theme-toggle" id="themeToggle" aria-label="Toggle dark mode" title="Toggle dark mode">&#9790;</button>
<button class="scroll-top" aria-label="Scroll to top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
</script>
<script>
if('serviceWorker' in navigator){navigator.serviceWorker.register('sw.js');}
(function(){var t=document.getElementById('themeToggle');var saved=localStorage.getItem('theme');if(saved){document.documentElement.setAttribute('data-theme',saved);t.textContent=saved==='dark'?'\u2600':'\u263E';}t.addEventListener('click',function(){var d=document.documentElement.getAttribute('data-theme')==='dark'?'':'dark';document.documentElement.setAttribute('data-theme',d);localStorage.setItem('theme',d);t.textContent=d==='dark'?'\u2600':'\u263E';});})();
</script></body></html>